Boston Scientific (NYSE:BSX) announced today that it received FDA 510(k) clearance for its Asurys fluid management system.
Probability of Remaining Event-Free at 24 Months by Kaplan-Meier Analysis After Achieving Complete Response at Three Months ...
New technology designed to provide a single irrigation management system for ureteroscopy, cystoscopy, percutaneous nephrolithotomy (PCNL) and benign prostatic hyperplasia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results